Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omzotirome for Cardiovascular Risk in Diabetes, Dyslipidemia, and Hypertension
NCT03254446Phase 3Unknown
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Mar 2018
- Primary completion
- Apr 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of omzotirome in type 2 diabetes mellitus (T2DM), dyslipidemia, hypertension (HTN), sponsored by Torrent Pharmaceuticals Limited. Status: unknown.
02
Drugs
omzotirome
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT03254446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254446.